Advertisement
Advertisement
IRWD
Ironwood Pharmaceuticals, Inc. - Class A
4.37
USDSponsored
+0.33
+8.17%
Apr 15, 16:00 UTC -4
Closed
After-Market
4.41
+0.04
+0.92%
IRWD Earnings Reports
Positive Surprise Ratio
IRWD beat 21 of 40 last estimates.
53%
Next Report
Date of Next Report
Apr 30, 2026
Estimate for Q1 26 (Revenue/ EPS)
$93.93M
/$0.24
Implied change from Q4 25 (Revenue/ EPS)
+96.88%
/-2500.00%
Implied change from Q1 25 (Revenue/ EPS)
+128.30%
/-271.43%
Ironwood Pharmaceuticals, Inc. - Class A earnings per share and revenue
On Feb 25, 2026, IRWD reported earnings of -0.01 USD per share (EPS) for Q4 25, missing the estimate of 0.01 USD, resulting in a -198.04% surprise. Revenue reached 47.71 million, compared to an expected 51.95 million, with a -8.17% difference. The market reacted with a -2.39% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 0.24 USD, with revenue projected to reach 93.93 million USD, implying an decrease of -2500.00% EPS, and increase of 96.88% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Evotec SE - ADR
Report Date
Apr 08, 2026 For Q4 25
Estimate
$0.31
Actual
$0.08
Surprise
-74.45%
Traws Pharma, Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$1.24
Actual
-$0.71
Surprise
+43.13%
Cosmos Holdings Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.14
Surprise
-243.14%
BIOMERICA INC
Report Date
Apr 13, 2026 For Q3 26
Estimate
-Actual
-$0.44
Surprise
-
FAQ
What were Ironwood Pharmaceuticals, Inc. - Class A's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Ironwood Pharmaceuticals, Inc. - Class A reported EPS of -$0.01, missing estimates by -198.04%, and revenue of $47.71M, -8.17% below expectations.
How did the market react to Ironwood Pharmaceuticals, Inc. - Class A's Q4 2025 earnings?
The stock price moved down -2.39%, changed from $4.61 before the earnings release to $4.50 the day after.
When is Ironwood Pharmaceuticals, Inc. - Class A expected to report next?
The next earning report is scheduled for Apr 30, 2026.
What are the forecasts for Ironwood Pharmaceuticals, Inc. - Class A's next earnings report?
Based on 4
analysts, Ironwood Pharmaceuticals, Inc. - Class A is expected to report EPS of $0.24 and revenue of $93.93M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement